Cash at the end of the last quarter was $2.2mil + $1.7mil for the R&D refund that wasn't included in the April quarterly. So they've got $3.9mil in instant cash with a burn rate of ~ $900k per quarter. So plenty of cash to fund existing needs.
Assuming all things positive - the raising may be to fund the next HIV clinical trials. Or to cover costs associated with the FDA application. Does anyone know how much an FDA app costs?
- Forums
- ASX - By Stock
- BIT
- Ann: Trading Halt
Ann: Trading Halt, page-11
Featured News
Add BIT (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.0¢ |
Change
0.001(2.63%) |
Mkt cap ! $17.59M |
Open | High | Low | Value | Volume |
2.0¢ | 2.0¢ | 2.0¢ | $2.95K | 150.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 1679605 | 1.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.0¢ | 229686 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 1679605 | 0.019 |
12 | 2341165 | 0.018 |
5 | 688000 | 0.017 |
10 | 1492350 | 0.016 |
5 | 760000 | 0.015 |
Price($) | Vol. | No. |
---|---|---|
0.020 | 238722 | 4 |
0.021 | 188000 | 3 |
0.022 | 600000 | 2 |
0.023 | 323000 | 3 |
0.024 | 255035 | 3 |
Last trade - 10.58am 13/11/2024 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online